Search Results

You are looking at 101 - 110 of 395 items for :

  • pharmacokinetics x
Clear All
Open access

Tapani Keränen and Hanna Kuusisto

. Pharmacotherapy, 2007, 278: 1202-1205. Mancl E.E., Gidal B.E.: The effect of carbapenem antibiotics on plasma concentrations of valproic acid. Ann. Pharmacother., 2009, 43: 2082-2087. Omoda K., Murakami T., Yumoto R., Nagai J., Maeda Y., Kiribayashi Y., Takano M.: Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. J. Pharm. Sci., 2005, 8: 1685-1693. Park M.K., Lim K.S., Kim T.E., Han H.K., Yi S.J., Shin K.H. et al.: Reduced valproic acid serum

Open access

Aleksandra Dimitrijevic

of Clinical Endocrinology & Metabolism 60.1 (1985): 156-163. 4. Kekkonen, Raimo, et al. “Pharmacokinetics of mifepristone after low oral doses.” Contraception 54.4 (1996): 229-234. 5. Peyron, Remi, et al. “Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.” New England Journal of Medicine 328.21 (1993): 1509-1513. 6. Ledger, W. L., et al. “Inhibition of ovulation by low-dose mifepristone (RU 486).” Human Reproduction 7.7 (1992): 945-950. 7. Batista, Marcelo C., et al. “Delayed

Open access

Ana Reis-Mendes, Marisa Alves, Félix Carvalho, Fernando Remião, Maria Lourdes Bastos and Vera Marisa Costa

toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol 26 : 1285–1311. Costa VM, Silva R, Tavares LC, Vitorino R, Amado F, Carvalho F, Bastos ML, Carvalho M, Carvalho RA, Remiao F. (2009). Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology 260 : 84–96. Dawson LK, Jodrell DI, Bowman A, Rye R, Byrne B, Bernareggi A, Camboni G, Smyth JF. (2000). A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue

Open access

Alexandru Robert Vlad and Andreea Ioana Lungu

-Deficit Hyperactivity Disorder in Athletes, Curr Sports Med Rep. 2011;10(1):32-36. 23. Comiran E, Kessler FH, Fröehlich PE et al - Lisdexamfetamine: A pharmacokinetic review, Eur J Pharm Sci. 2016;89:172–179. 24. Garnock-Jones KP, Keating GM - Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents, Pediatr Drugs. 2009;11(3):203-226. 25. Strange BC– Once-daily treatment of ADHD with guanfacine: patient implications. Neuro psychiatr Dis Treat. 2008;4(3):499-506. 26. Söderlund GBW, Björk C, and Gustafsson P

Open access

Miroslav Pohanka, Oto Pavlis, Hana Svobodova and Jiri Pikula

: 384-388. Yamamoto K, Sawada Y and Iga T. (1995). Comparative pharmacokinetics of four cholinesterase inhibitors in rats. Biol Pharm Bull   18 : 1292-1295. Yee D, Rhinebbart-Jones TR and Elkins L. (1996). Loss of either CD4+ or DC8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen Francisella tularensis strain LVS. J Immunol   157 : 5042-5048.

Open access

Tadej Battelino

-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics. Eur J Endocrinol 2011; 165: 401-9. 5. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J. et al. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 2012; 97: E694-9. 6. Kotnik P, Keuper M, Wabitsch M, Fischer-Posovszky P. Interleukin-1β downregulates RBP4 secretion in human adipocytes. PLoS

Open access

Roshan Kumar Sahu, Bhupendra Singh, Shubhini A. Saraf, Gaurav Kaithwas and Kamal Kishor

. Chromatographia 2009;69(Supplement):115-22. doi: 10.1365/s10337-009-1082-3 21. Epaulard O, Saint-Raymond C, Villier C, Charles J, Roch N, Beani JC, Leccia MT. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbiol Infect 2010;16:1362-4. doi: 10.1111/j.1469-0691.2009.03124.x 22. Scholz I, Oberwittler H, Riedel KD, Burhenne J, Weiss J, Haefeli WE, Mikus G. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation

Open access

Rune Andersen Hartvig, Niels Bjerre Holm, Petur Weihe Dalsgaard, Lotte Ask Reitzel, Irene Breum Müller and Kristian Linnet

[12] Henninge J., Pepaj, M., Hullstein, I., Hemmersbach, P., Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation, Drug Test Analysis., 2010, 2, 647-650 [13] Mock S., Shen, X., Tamvakopoulos, C., Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration, Rapid Commun. Mass Spectrom., 2002, 16, 2142-2147 [14] Tamvakopoulos C., Mass spectrometry for the

Open access

Viera Kristová, Milan Kriška, Róbert Vojtko, Miriam Petrová, Silvia Líšková, Radoslav Villáris, Zoltán Varga and Martin Wawruch

, Kriška M, Kovalčík V. (1978). Bayliss myogenic response in the isolated ductus arteriosus of guinea-pig and rabbit fetuses. Experientia   34 : 745-746. Turnheim K. (2003). When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol   38 : 843-853. Varga Z, Kriška M, Kristová V, Hudec. (2010). Prescription of NSAIDs and risk of cardiovascular adverse effects in hospitalized patients. Rheumatologia 24 : 87-90. Vojtko R., Villaris R., Petrová M., Líšková S

Open access

Nandita Saxena, Yangchen Doma Bhutia, Om Kumar, Pooja Phatak and Ramesh Kumar Kaul

. Garg V, Hon YY, Jusko WJ. (1994). Effects of acute and chronic inflammation on the pharmacokinetics of prednisolone in rats. Pharm Res 11 : 541–4. Griffiths GD. (2011). Understanding ricin from a defensive viewpoint. 3 : 1373–92. Kerksick C, Willoughby D. (2005). The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 9 : 38–44. Kumar O, Sugendran K, Vijayaraghavan R. (2003). Oxidative stress associated hepatic and renal toxicity induced by ricin in mice. Toxicon 41